slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 51,031-51,060
Pages 10,126
Rows per page 30
Component
51,031-51,060 of 303,780
05
The slide uses a phylogenetic tree and a dot plot to compare neutralization potency (IC50) across different viral strains.Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
06
The slide contrasts cocktail-based strategies (colored dots) with a single broadly neutralizing antibody (black dots) against various SARS-related coronaviruses.Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
07
The slide uses a heatmap to visualize IC50 values, where red indicates higher potency (lower IC50).Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
08
The table uses a color-coded heatmap to represent IC50 values, with red indicating higher potency (lower IC50).Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
09
The slide includes a disclaimer about the lack of head-to-head trials and the investigational status of ADG20.Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
10
The table uses color-coding to represent IC50 potency, with red indicating higher potency (lower IC50) and grey indicating lower potency.Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
11
The table uses a color-coded scale to represent potency (IC50), where red indicates higher potency (lower IC50) and white/grey indicates lower potency.Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
12
The slide includes a disclaimer about the lack of head-to-head trials and the investigational status of ADG20.Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
13
The table uses a color-coded scale to represent IC50 potency, with red indicating high potency (low IC50) and grey indicating low potency (high IC50).Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
14
The table uses a color-coded heatmap where red indicates higher potency (lower IC50 values) and yellow/white indicates lower potency. Includes disclaimers about lack of head-to-head trials.Adagio Therapeutics | Investor Conference Presentation Deck | 19 slides · Adagio Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
17
The slide uses a combination of big numbers and a bulleted list of qualitative growth drivers.PowerSchool | Investor Presentation Deck | 28 slides · PowerSchool
Pitch deck Investor relations Beat · Traction2 hits
27
Includes footnotes explaining the nature of adjustments (share-based compensation, restructuring, acquisition-related expenses, amortization).PowerSchool | Investor Presentation Deck | 28 slides · PowerSchool
Pitch deck Investor relations 2 hits
28
Includes detailed footnotes explaining specific line items like management fees, restructuring, and acquisition-related expenses.PowerSchool | Investor Presentation Deck | 28 slides · PowerSchool
Pitch deck Investor relations 2 hits
01
Rentokil Initial | Mergers and Acquisitions Presentation Deck | 21 slidesRentokil Initial | Mergers and Acquisitions Presentation Deck | 21 slides · Rentokil Initial
Conference presentation Investment bank Beat · Setup2 hits
08
The slide uses a combination of bulleted strategic points and supporting data (table and donut chart) to justify the acquisition.Rentokil Initial | Mergers and Acquisitions Presentation Deck | 21 slides · Rentokil Initial
Conference presentation Investment bank Beat · Future Vision (Gain)2 hits
09
The slide uses a circular 'Operational Model' diagram to illustrate the integration strategy.Rentokil Initial | Mergers and Acquisitions Presentation Deck | 21 slides · Rentokil Initial
Conference presentation Investment bank Beat · Future Vision (Gain)2 hits
09
Rubicon Technologies | SPAC Presentation Deck | 49 slidesRubicon Technologies | SPAC Presentation Deck | 49 slides · Rubicon Technologies
Pitch deck Investment bank 2 hits
13
The slide uses a 'Digital Challenger' framing to contrast with traditional waste management companies.Rubicon Technologies | SPAC Presentation Deck | 49 slides · Rubicon Technologies
Pitch deck Investment bank Beat · Problem2 hits
15
Uses a split-screen layout to frame the problem (left) and the solution (right).Rubicon Technologies | SPAC Presentation Deck | 49 slides · Rubicon Technologies
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction2 hits
20
Uses a split-screen layout to contrast legacy industry pain points with the company's value proposition.Rubicon Technologies | SPAC Presentation Deck | 49 slides · Rubicon Technologies
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle2 hits
01
Snowflake | Investor Presentation Deck | 26 slidesSnowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations 2 hits
13
The chart tracks contracted future revenue (RPO) from Q3 FY21 to Q3 FY22.Snowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
15
The chart tracks customer count from Q3 FY21 to Q3 FY22.Snowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
16
The slide includes a detailed footnote explaining the methodology for calculating the Dollar-Based Net Revenue Retention Rate.Snowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
19
The chart illustrates aggressive headcount expansion across all departments, with S&M being the largest segment.Snowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
20
The chart illustrates a gradual shift in revenue contribution from the Americas to EMEA and APJ.Snowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
23
The table provides a detailed breakdown of stock-based compensation and amortization of acquired intangibles as adjustments to GAAP figures.Snowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations 2 hits
24
The table details adjustments for stock-based compensation, amortization of intangibles, and acquisition-related expenses.Snowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations 2 hits
25
Includes reconciliation for operating income, free cash flow, and adjusted free cash flow.Snowflake | Investor Presentation Deck | 26 slides · Snowflake
Pitch deck Investor relations 2 hits
17
The slide uses a structured table format to present key deal terms and benefits.Xometry | Mergers and Acquisitions Presentation Deck | 23 slides · Xometry
Deck Investment bank Loop · Why Now2 hits